Search

Your search keyword '"Molybdenum pharmacokinetics"' showing total 88 results

Search Constraints

Start Over You searched for: Descriptor "Molybdenum pharmacokinetics" Remove constraint Descriptor: "Molybdenum pharmacokinetics"
88 results on '"Molybdenum pharmacokinetics"'

Search Results

1. Controlled decoration of nanoceria on the surface of MoS 2 nanoflowers to improve the biodegradability and biocompatibility in Drosophila melanogaster model.

2. Pulmonary toxicity, genotoxicity, and carcinogenicity evaluation of molybdenum, lithium, and tungsten: A review.

3. Tonoplast-Localized OsMOT1;2 Participates in Interorgan Molybdate Distribution in Rice.

4. Molybdenum derived from nanomaterials incorporates into molybdenum enzymes and affects their activities in vivo.

5. Differential Phagocytosis-Based Photothermal Ablation of Inflammatory Macrophages in Atherosclerotic Disease.

6. "Bottom-up" preparation of MoS 2 quantum dots for tumor imaging and their in vivo behavior study.

7. Release dynamics of As, Co, and Mo in a biochar treated soil under pre-definite redox conditions.

8. Translocation, biotransformation-related degradation, and toxicity assessment of polyvinylpyrrolidone-modified 2H-phase nano-MoS 2 .

9. A two-generation reproductive toxicity study of sodium molybdate dihydrate administered in drinking water or diet to Sprague-Dawley rats.

10. Metabolic disposition of WTX101 (bis-choline tetrathiomolybdate) in a rat model of Wilson disease.

11. Methylene Blue-Fortified Molybdenum Trioxide Nanoparticles: Harnessing Radical Scavenging Property.

12. Intracellular Mechanistic Understanding of 2D MoS 2 Nanosheets for Anti-Exocytosis-Enhanced Synergistic Cancer Therapy.

13. Changes in the fractionation profile of Al, Ni, and Mo during bioleaching of spent hydroprocessing catalysts with Acidithiobacillus ferrooxidans.

14. Dietary determinants of urinary molybdenum levels in Mexican women: a pilot study.

15. Uptake, transport and distribution of molybdenum in two oilseed rape (Brassica napus L.) cultivars under different nitrate/ammonium ratios.

16. Biomonitoring Equivalents for molybdenum.

17. Optimal Contrast Agent Staining of Ligaments and Tendons for X-Ray Computed Tomography.

18. Degradable Molybdenum Oxide Nanosheets with Rapid Clearance and Efficient Tumor Homing Capabilities as a Therapeutic Nanoplatform.

19. Smart MoS2/Fe3O4 Nanotheranostic for Magnetically Targeted Photothermal Therapy Guided by Magnetic Resonance/Photoacoustic Imaging.

20. Pharmacologic evaluation of ammonium tetrathiomolybdate after intravenous and oral administration to healthy dogs.

21. Mononuclear dioxomolybdenum(VI) thiosemicarbazonato complexes: Synthesis, characterization, structural illustration, in vitro DNA binding, cleavage, and antitumor properties.

22. 90-Day subchronic toxicity study of sodium molybdate dihydrate in rats.

23. In-vivo evaluation of the permeability of the blood-brain barrier to arsenicals, molybdate, and methylmercury by use of online microdialysis-packed minicolumn-inductively coupled plasma mass spectrometry.

24. Serum metal levels after minimally invasive repair of pectus excavatum.

25. Effects of clonidine and idazoxan on tetrathiomolybdate-induced copper and lysosomal enzyme excretion into sheep bile.

26. Role of the rumen in copper and thiomolybdate absorption.

27. Cobalt, chromium and molybdenum ions kinetics in the human body: data gained from a total hip replacement with massive third body wear of the head and neuropathy by cobalt intoxication.

28. The influence of soil properties on the toxicity of molybdenum to three species of soil invertebrates.

29. Influence of soil properties on molybdenum uptake and elimination kinetics in the earthworm Eisenia andrei.

30. Morpho-physiological and biochemical responses in the floating lamina of Trapa natans exposed to molybdenum.

31. Copper chelation in cancer therapy using tetrathiomolybdate: an evolving paradigm.

32. Phase I study of copper-binding agent ATN-224 in patients with advanced solid tumors.

33. A recycling systemic model for the biokinetics of molybdenum radionuclides.

34. Tetrathiomolybdate, a copper chelator for the treatment of Wilson disease, pulmonary fibrosis and other indications.

35. Screening the phytoremediation potential of desert broom (Baccharis sarothroides Gray) growing on mine tailings in Arizona, USA.

36. Cobalt-chromium-molybdenum alloy causes metal accumulation and metallothionein up-regulation in rat liver and kidney.

37. The biological and toxicological importance of molybdenum in the environment and in the nutrition of plants, animals and man. Part 2: Molybdenum in animals and man.

38. Mineral deficiency in patients who have undergone gastrectomy.

39. Modelling urinary excretion of molybdenum after oral and intravenous administration of stable tracers.

40. Molybdenum intake influences molybdenum kinetics in men.

41. Modest copper supplementation blocks molybdenosis in cattle.

42. Influence of copper status on the accumulation of toxic and essential metals in cattle.

43. Rates of intestinal absorption of molybdenum in humans.

44. Molybdenum kinetics in men differ during molybdenum depletion and repletion.

45. Gut transport of a molybdenum/ascorbic acid complex.

46. Plasma molybdenum reflects dietary molybdenum intake.

47. Effect of alkaline-stabilized biosolids on alfalfa molybdenum and copper content.

48. Recombinant Rhodobacter capsulatus xanthine dehydrogenase, a useful model system for the characterization of protein variants leading to xanthinuria I in humans.

49. Sensitivity analysis techniques applied to a revised model of molybdenum biokinetics.

50. Physiological impact of acute molybdenum exposure in juvenile kokanee salmon (Oncorhynchus nerka).

Catalog

Books, media, physical & digital resources